BDBM50165166 CHEMBL441920 Radiolabeled octreotide derivative
CHEMBL262135 BDBM50165170 Radiolabeled octreotide derivative
CHEMBL386768 BDBM50165169 Radiolabeled octreotide derivative
CHEMBL262135 BDBM50165164 Radiolabeled octreotide derivative CHEMBL430066
CHEMBL386768 CHEMBL413647 BDBM50165161 Radiolabeled octreotide derivative
Edotreotide BDBM50165171 CHEMBL408350 Radiolabeled octreotide derivative
10-(4-Amino-butyl)-19-(2-amino-3-phenyl-propionylamino)-16-(4-hydroxy-benzyl)-7-(1-hydroxy-ethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaaza-cycloicosane-4-carboxylic acid (2-hydroxy-1-hydroxymethyl-propyl)-amide CHEMBL265525 octreotide-Tyr3 BDBM50112636
BDBM50059090 CHEMBL405598 10-(4-Amino-butyl)-19-(2-amino-3-phenyl-propionylamino)-16-benzyl-7-(1-hydroxy-ethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaaza-cycloicosane-4-carboxylic acid (2-hydroxy-1-hydroxymethyl-propyl)-amide octreotide SMS 201-995
4-[(4R,7S,10S,13R,16S)-19-(2-azaniumyl-3-phenylpropanamido)-4-{[(2R)-1,3-dihydroxybutan-2-yl]carbamoyl}-7-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium BDBM50165176 Radiolabeled octreotide derivative
4-[(4R,7S,10S,13R,16S)-19-(2-azaniumyl-3-phenylpropanamido)-4-{[(1S)-1-carboxy-2-hydroxypropyl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium BDBM50165183 Radiolabeled octreotide derivative
4-[(4R,7S,10S,13R,16S)-19-(2-azaniumyl-3-phenylpropanamido)-4-{[(2R)-1,3-dihydroxybutan-2-yl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium BDBM50165172 Radiolabeled octreotide derivative
4-[(4R,7S,10S,13R,16S)-19-(2-azaniumyl-3-phenylpropanamido)-4-{[(2R)-1,3-dihydroxybutan-2-yl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium BDBM50165186 Radiolabeled octreotide derivative
BDBM50165167 4-[(4R,7S,10S,13R,16S)-19-(2-azaniumyl-3-phenylpropanamido)-4-{[(1S)-1-carboxy-2-hydroxypropyl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium Radiolabeled octreotide derivative
BDBM50165168 4-[(4R,7S,10S,13R,16S)-4-{[(1S)-1-carboxy-2-hydroxypropyl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[3-phenyl-2-({[(4R)-2,3,4,5-tetrahydroxyoxan-2-yl]methyl}azaniumyl)propanamido]-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium Radiolabeled octreotide derivative
BDBM50165177 Radiolabeled octreotide derivative 4-[(4R,7S,10S,13R,16S)-4-{[(2R)-1,3-dihydroxybutan-2-yl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[3-phenyl-2-({[(4R)-2,3,4,5-tetrahydroxyoxan-2-yl]methyl}azaniumyl)propanamido]-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium
BDBM50165178 4-[(4R,7S,10S,13R,16S)-4-{[(1S)-1-carboxy-2-hydroxypropyl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[3-phenyl-2-({[(4R)-2,3,4,5-tetrahydroxyoxan-2-yl]methyl}azaniumyl)propanamido]-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium Radiolabeled octreotide derivative
BDBM50165179 Radiolabeled octreotide derivative 4-[(4R,7S,10S,13R,16S)-4-{[(2R)-1,3-dihydroxybutan-2-yl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[3-phenyl-2-({[(4R)-2,3,4,5-tetrahydroxyoxan-2-yl]methyl}azaniumyl)propanamido]-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium
4-[(4R,7S,10S,13R,16S)-4-{[(1S)-1-carboxy-2-hydroxypropyl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[3-phenyl-2-(3-{[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propanamido)propanamido]-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium BDBM50165182 Radiolabeled octreotide derivative
4-[(4R,7S,10S,13R,16S)-4-{[(1S)-1-carboxy-2-hydroxypropyl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[3-phenyl-2-(3-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propanamido)propanamido]-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium Radiolabeled octreotide derivative BDBM50165163
4-[(4R,7S,10S,13R,16S)-4-{[(2R)-1,3-dihydroxybutan-2-yl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[3-phenyl-2-(3-{[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propanamido)propanamido]-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium Radiolabeled octreotide derivative BDBM50165185
4-[(4R,7S,10S,13R,16S)-4-{[(2R)-1,3-dihydroxybutan-2-yl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[3-phenyl-2-(3-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propanamido)propanamido]-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium BDBM50165173 Radiolabeled octreotide derivative
4-[(4R,7S,10S,13R,16S)-4-{[(2R)-1,3-dihydroxybutan-2-yl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[3-phenyl-2-({[(4R)-2,3,5-trihydroxy-4-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl}azaniumyl)propanamido]-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium BDBM50165160 Radiolabeled octreotide derivative
4-[(4R,7S,10S,13R,16S)-4-{[(2R)-1,3-dihydroxybutan-2-yl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[3-phenyl-2-({[(4R)-2,3,5-trihydroxy-4-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl}azaniumyl)propanamido]-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium BDBM50165184 Radiolabeled octreotide derivative
BDBM50165159 4-[(4R,7S,10S,13R,16S)-4-{[(1S)-1-carboxy-2-hydroxypropyl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[3-phenyl-2-({[(4R)-2,3,5-trihydroxy-4-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl}azaniumyl)propanamido]-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium Radiolabeled octreotide derivative
4-[(4R,7S,10S,13R,16S)-19-[2-({[(4R)-4-{[(2S,4R,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2,3,5-trihydroxyoxan-2-yl]methyl}azaniumyl)-3-phenylpropanamido]-4-{[(2R)-1,3-dihydroxybutan-2-yl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium BDBM50165175 Radiolabeled octreotide derivative
4-[(4R,7S,10S,13R,16S)-19-[2-({[(4R)-4-{[(2S,4R,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2,3,5-trihydroxyoxan-2-yl]methyl}azaniumyl)-3-phenylpropanamido]-4-{[(2R)-1,3-dihydroxybutan-2-yl]carbamoyl}-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium Radiolabeled octreotide derivative BDBM50165174
4-[(4R,7S,10S,13R,16S)-4-{[(1S)-1-carboxy-2-hydroxypropyl]carbamoyl}-19-[2-({[(4R)-4-{[(2S,4R,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2,3,5-trihydroxyoxan-2-yl]methyl}azaniumyl)-3-phenylpropanamido]-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium BDBM50165181 Radiolabeled octreotide derivative
BDBM50165180 4-[(4R,7S,10S,13R,16S)-4-{[(1S)-1-carboxy-2-hydroxypropyl]carbamoyl}-19-[2-({[(4R)-4-{[(2S,4R,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2,3,5-trihydroxyoxan-2-yl]methyl}azaniumyl)-3-phenylpropanamido]-16-[(4-hydroxy-3-iodophenyl)methyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl]butan-1-aminium Radiolabeled octreotide derivative
OCTREOTIDE 2-{[(13R,16S,19R)-10-(4-Amino-butyl)-19-((S)-2-amino-3-phenyl-propionylamino)-16-benzyl-7-(1-hydroxy-ethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaaza-cycloicosane-4-carbonyl]-amino}-3-hydroxy-butyric acid BDBM50272772 10-(4-Amino-butyl)-19-(2-amino-3-phenyl-propionylamino)-16-benzyl-7-(1-hydroxy-ethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaaza-cycloicosane-4-carboxylic acid (2-hydroxy-1-hydroxymethyl-propyl)-amide CHEMBL1680 10-(4-Amino-butyl)-19-(2-amino-3-phenyl-propionylamino)-16-benzyl-7-(1-hydroxy-ethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaaza-cycloicosane-4-carboxylic acid (2-hydroxy-1-
- Albert, R; Smith-Jones, P; Stolz, B; Simeon, C; Knecht, H; Bruns, C; Pless, J Direct synthesis of [DOTA-DPhe1]-octreotide and [DOTA-DPhe1,Tyr3]-octreotide (SMT487): two conjugates for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man. Bioorg Med Chem Lett 8: 1207-10 (1999)
- Weckbecker, G; Pally, C; Raulf, F; Beckmann, N; Schuurman, JH; Rudin, M; Bruns, C The somatostatin analog octreotide as potential treatment for re-stenosis and chronic rejection. Transplant Proc 29: 2599-600 (1997)
- Siehler, S; Seuwen, K; Hoyer, D [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors. Eur J Pharmacol 348: 311-20 (1998)
- Edwards, WB; Fields, CG; Anderson, CJ; Pajeau, TS; Welch, MJ; Fields, GB Generally applicable, convenient solid-phase synthesis and receptor affinities of octreotide analogs. J Med Chem 37: 3749-57 (1994)
- Di Cianni, A; Carotenuto, A; Brancaccio, D; Novellino, E; Reubi, JC; Beetschen, K; Papini, AM; Ginanneschi, M Novel octreotide dicarba-analogues with high affinity and different selectivity for somatostatin receptors. J Med Chem 53: 6188-97 (2010)
- Su, JC; Tseng, CL; Chang, TG; Yu, WJ; Wu, SK A synthetic method for peptide-PEG-lipid conjugates: application of octreotide-PEG-DSPE synthesis. Bioorg Med Chem Lett 18: 4593-6 (2008)
- Grace, CR; Erchegyi, J; Samant, M; Cescato, R; Piccand, V; Riek, R; Reubi, JC; Rivier, JE Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivity. J Med Chem 51: 2676-81 (2008)
- Smith, LJ; Rought Whitta, G; Dolenc, J; Wang, D; van Gunsteren, WF A molecular dynamics simulation investigation of the relative stability of the cyclic peptide octreotide and its deprotonated and its (CF Bioorg Med Chem 24: 4936-4948 (2016)
- Deshmukh, MV; Voll, G; Kühlewein, A; Mäcke, H; Schmitt, J; Kessler, H; Gemmecker, G NMR studies reveal structural differences between the gallium and yttrium complexes of DOTA-D-Phe1-Tyr3-octreotide. J Med Chem 48: 1506-14 (2005)
- Schottelius, M; Reubi, JC; Eltschinger, V; Schwaiger, M; Wester, HJ N-terminal sugar conjugation and C-terminal Thr-for-Thr(ol) exchange in radioiodinated Tyr3-octreotide: effect on cellular ligand trafficking in vitro and tumor accumulation in vivo. J Med Chem 48: 2778-89 (2005)
- Yim, CB; Dijkgraaf, I; Merkx, R; Versluis, C; Eek, A; Mulder, GE; Rijkers, DT; Boerman, OC; Liskamp, RM Synthesis of DOTA-conjugated multimeric [Tyr3]octreotide peptides via a combination of Cu(I)-catalyzed"click" cycloaddition and thio acid/sulfonyl azide"sulfo-click" amidation and their in vivo evaluation. J Med Chem 53: 3944-53 (2010)